Immunetune
OverviewSuggest Edit
Immunetune is a biotech company that develops personalized DNA-based vaccines to treat highly mutated cancer types, including melanoma, lung, and colon cancer. It designs vaccines that train the immune system to selectively identify and eliminate tumor cells based on tumor-specific DNA mutations (neoantigens).
| Type | Private | |
| Founded | 2016 | |
| HQ | Leiden, NL | Map |
| Website | immunetune.nl |
Locations
Latest Updates
| Employees (est.) (Jan 2021) | 4 | (-20%) |
| Cybersecurity rating | A | More |
Key People/Management at Immunetune
Gerben Zondag
CEO
Roger Legtenberg
CBO
Jeroen van Bergen
CSO
Rene de Keijzer
CFO
Immunetune Office Locations
Immunetune has an office in Leiden
Leiden, NL (HQ)
Biopartner Gebouw 2, J.H. Oortweg 19
Immunetune Financials and Metrics
Summary Metrics
Founding Date | 2016 |
Immunetune Cybersecurity Score
Immunetune Online and Social Media Presence
Immunetune's Trends
Immunetune Frequently Asked Questions
When was Immunetune founded?
Immunetune was founded in 2016.
Who are Immunetune key executives?
Immunetune's key executives are Gerben Zondag, Roger Legtenberg and Jeroen van Bergen.
How many employees does Immunetune have?
Immunetune has 4 employees.
Who are Immunetune competitors?
Competitors of Immunetune include MolMed, BlinkBio and Xilio Therapeutics.
Where is Immunetune headquarters?
Immunetune headquarters is located at Biopartner Gebouw 2, J.H. Oortweg 19, Leiden.
Where are Immunetune offices?
Immunetune has an office in Leiden.
How many offices does Immunetune have?
Immunetune has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies